Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 4
- DOI:
- No doi available
- Key Word:
- nucleostemin;prostatic neoplasms;PC-3;RNA interference
Abstract： Background Nucleostemin is essential for the proliferation and survival of stem and cancer cells,but it is unknown whether this newly identified molecule is involved in prostate cancer pathogenesis.Methods Total RNA and protein were extracted from prostate cancer tissues and PC-3,LNCap and DU145 cell lines.The nucleostemin mRNA and protein expression were measured by RT-PCR and Western blot.Immunohistochemistry was also used to detect the nucleostemin protein expression in prostate cancer tissues and PC-3 cells.A nucleostemin specific,short hairpin RNA,expression plasmid was used to transfect PC-3 cells.The changes of nucleostemin gene were detected and the proliferative capacity of the cells was determined.Results Nucleostemin was highly expressed in prostate cancer tissues and cell lines.Nucleostemin expression level in the silencer group PC-3 cells remarkably reduced.The proliferation rate of silencer group PC-3 cells decreased and the percentage of G1 stage cells increased.The neoplasm forming capacity in nude mice of the silencer group PC-3 cells decreased significantly.Conclusions Nucleostemin is highly expressed in prostate cancer tissues and cell lines.The proliferative capacity of PC-3 cells is remarkably reduced after silencing nucleostemin gene expression.
- [1]Hai-Xia Yang,Geng-Lin Jin,Ling Meng,etc.Screening and identification of proteins interacting with nucleostemin[J].2005,(31).
- [2]ZHONG Wei-de,HE Hui-chan,BI Xue-cheng,etc.cDNA macroarray for analysis of gene expression profiles in prostate cancer[J].2006,(7).
- [3]Si-Jin Liu,Zi-wei Cai,Ya-Jun Liu,etc.Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies[J].2004,(9).
- [4]Smigal C,Siegel R,Ward E,etc.Cancer statistics, 2006.[J].2006,56(2).
- [5]Yang H,Shou C,Wu J,etc.Preparation and characterization of monoclonal antibodies against nucleostemin, a protein that controls cell proliferation in stem cells and cancer cells.[J].2005,24(1).
- [6]Ekman P,Fan Y,Lou F,etc.Nucleostemin mRNA is expressed in both normal and malignant renal tissues.[J].2006,94(11).
- [7]Lucia MS,Van Bokhoven A,Johannes WU,etc.Molecular characterization of human prostate carcinoma cell lines.[J].2003,57(3).
- [8]B, McCright,D M, Virshup.Identification of a new family of protein phosphatase 2A regulatory subunits.[J].1995,270.
- [9]Guofa H,Yan X,Siguo L,etc.The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells.[J].2004,23(3).
- [10]Y, Sun,H, Kim,M, Parker,etc.Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness.[J].1900,16.
- [11]B, McCright,A R, Brothman,D M, Virshup.Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12.[J].1996,36.
- [12]Tsai RY,McKay RD.A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin.[J].2005,168(2).
- [13]E D, Crawford,M A, Eisenberger,D G, McLeod,etc.A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.[J].1989,321(7).
- [14]Martens E,Stevens I,Janssens V,etc.Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice.[J].2004,336(4).
- [15]Rubbi CP,Milner J.Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus.[J].2000,19(1).
- [16]Misteli T.Going in GTP cycles in the nucleolus.[J].2005,168(2).
- [17]S, Takagi,M L, McFadden,R E, Humphreys,etc.Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment.[J].1993,14(6).